Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

18 Periodical Search Results

You searched for "fulvestrant" OR "zd9238" OR "zd 9238" OR "faslodex" OR "zm182780" OR "zd182780" OR "zd 182780" OR "zm 182780" OR "ici182780" OR "ici 182780" OR "ici 182 780" within Cancer Treatment Reviews

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-18  of 18 results  

Results Page:  [1]

display abstract citation download email a colleague
Display:

  1. Clinical development of fulvestrant (‘Faslodex’) , 04 October 2005
    Anthony Howell, Paul Abram
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S3-S9)
    Abstract | Full Text | Full-Text PDF (133 KB)

  1. Fulvestrant (‘Faslodex’) in clinical practice: International experience from a Compassionate Use Programme , 04 October 2005
    A. Howell
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S1-S2)
    Full Text | Full-Text PDF (56 KB)

  1. Case studies of fulvestrant (‘Faslodex’) in postmenopausal women with advanced breast cancer , 04 October 2005
    Paul Abram, Nicolai Maass, Daniel Rea, Sergio D. Simon, Guenther G. Steger
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S17-S25)
    Abstract | Full Text | Full-Text PDF (218 KB)

  1. The future of fulvestrant (‘Faslodex’) , 04 October 2005
    Anthony Howell
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S26-S33)
    Abstract | Full Text | Full-Text PDF (209 KB)

  1. Fulvestrant (‘Faslodex’): Clinical experience from the Compassionate Use Programme , 04 October 2005
    Guenther G. Steger, Maya Gips, Sergio D. Simon, Ana Lluch, Jefferson Vinholes, Bella Kaufman, Andrew Wardley, Louis Mauriac
    Cancer Treatment Reviews
    2005 (Vol. 31Supplement 2, Pages S10-S16)
    Abstract | Full Text | Full-Text PDF (109 KB)

  1. A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer , 23 May 2005
    David Dodwell, Ignace Vergote
    Cancer Treatment Reviews
    June 2005 (Vol. 31, Issue 4, Pages 274-282)
    Abstract | Full Text | Full-Text PDF (317 KB)

  1. Tamoxifen (‘Nolvadex’): a review: Antitumour treatment
    M Clemons, S Danson, A Howell
    Cancer Treatment Reviews
    August 2002 (Vol. 28, Issue 4, Pages 165-180)
    Abstract | Full Text | Full-Text PDF (293 KB)

  1. Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective , 02 November 2004
    John F.R. Robertson
    Cancer Treatment Reviews
    December 2004 (Vol. 30, Issue 8, Pages 695-706)
    Abstract | Full Text | Full-Text PDF (307 KB)

  1. The influence of endocrine treatments for breast cancer on health-related quality of life , 03 June 2008
    Ciska Buijs, Elisabeth G.E. de Vries, Marian J.E. Mourits, Pax H.B. Willemse
    Cancer Treatment Reviews
    November 2008 (Vol. 34, Issue 7, Pages 640-655)
    Abstract | Full Text | Full-Text PDF (205 KB)

  1. Neoadjuvant endocrine therapy in breast cancer , 29 November 2006
    M.J. Beresford, D. Ravichandran, A. Makris
    Cancer Treatment Reviews
    February 2007 (Vol. 33, Issue 1, Pages 48-57)
    Abstract | Full Text | Full-Text PDF (191 KB)

  1. Management of primary and advanced breast cancer in older unfit patients (medical treatment) , 17 September 2009
    M. Aapro, Silvio Monfardini, Antonio Jirillo, Umberto Basso
    Cancer Treatment Reviews
    October 2009 (Vol. 35, Issue 6, Pages 503-508)
    Abstract | Full Text | Full-Text PDF (167 KB)

  1. Hormonal therapy for male breast cancer: A different approach for a different disease , 14 February 2006
    Zeina A. Nahleh
    Cancer Treatment Reviews
    April 2006 (Vol. 32, Issue 2, Pages 101-105)
    Abstract | Full Text | Full-Text PDF (90 KB)

  1. Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies , 20 May 2008
    Robert E. Coleman, Jean-Jacques Body, Julie R. Gralow, Allan Lipton
    Cancer Treatment Reviews
    2008 (Vol. 34Supplement 1, Pages S31-S42)
    Abstract | Full Text | Full-Text PDF (346 KB)

  1. High-quality evidence in oncology from 18th May to 15th June 2004: a summary , 28 October 2004
    Benjamin Djulbegovic, Sam Vincent
    Cancer Treatment Reviews
    December 2004 (Vol. 30, Issue 8, Pages 721-723)
    Full Text | Full-Text PDF (218 KB)

  1. Novel therapeutic approaches to the treatment of metastatic breast cancer Corrected Proof, 02 November 2009
    Yolanda Fernández, Juan Cueva, Andrés G. Palomo, Manuel Ramos, Ana de Juan, Lourdes Calvo, Jesús García-Mata, Paula García-Teijido, Ignacio Peláez, Laura García-Estévez
    Cancer Treatment Reviews
    DOI: 10.1016/j.ctrv.2009.10.001
    Abstract | Full Text | Full-Text PDF (220 KB)

  1. Classification of anticancer drugs—a new system based on therapeutic targets
    Enrique Espinosa, Pilar Zamora, Jaime Feliu, Manuel González Barón
    Cancer Treatment Reviews
    December 2003 (Vol. 29, Issue 6, Pages 515-523)
    Abstract | Full Text | Full-Text PDF (138 KB)

  1. Irreversible pan-ErbB tyrosine kinase inhibitors and breast cancer: Current status and future directions Corrected Proof, 07 September 2009
    Alberto Ocaña, Eitan Amir
    Cancer Treatment Reviews
    DOI: 10.1016/j.ctrv.2009.08.001
    Abstract | Full Text | Full-Text PDF (439 KB)

  1. The role of nuclear receptors in pharmacokinetic drug–drug interactions in oncology , 25 April 2007
    S. Harmsen, I. Meijerman, J.H. Beijnen, J.H.M. Schellens
    Cancer Treatment Reviews
    June 2007 (Vol. 33, Issue 4, Pages 369-380)
    Abstract | Full Text | Full-Text PDF (272 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-18  of 18 results  

Results Page:  [1]

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.